ARCHIVES

UT-Houston Wins NIH Center Grant For Alternative Cancer Medicine Studies

This article is from The Cancer Letter archive.

Vol. 21 No. 42 | November 3, 1995

Download PDF Visit The Full Archive

Related Articles

EORTC Places Same Number on Phase 2-3 Trials As In U.S.

December 12, 1986

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

April 27, 2012

DCBDC Advisors Ok Training Grant Program In Clinical Oncology

February 22, 1991

FDA Advisors Debate Ban, Black Box And Status Quo of Power Morcellators

July 25, 2014

Bush Appoints Andrew von Eschenback, Of M. D. Anderson, As 12th NCI Director.

December 7, 2001

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

July 17, 2009